Course Director

Paul W. Noble, MD
Paul W. Noble, MD

Women's Guild Lung Institute
Cedars-Sinai Medical Center
Los Angeles, California

Accredited by

University of Cincinnati

Activity Details

Credit Types:CME
Credit Amount:1.0 Credits
Release Date:2017-Jun-26
Expiration Date:2018-Jun-25
Estimated Time for Completion:60 minutes
Registration Required:No
Cost:Free of charge

Activity Description and Educational Objectives

In this activity, an expert in pulmonary medicine discusses the latest advances in the identification and treatment of idiopathic pulmonary fibrosis.

Upon completion of this activity, participants should be better able to:
  • Describe the signs and symptoms of idiopathic pulmonary fibrosis (IPF)
  • Differentiate IPF from interstitial lung disorders according to evidence-based guidelines
  • Select IPF therapy according to current guidelines, relevant clinical data, and patient preferences
  • Implement evidence-based strategies for monitoring IPF treatment response, managing adverse events, and improving patient quality of life

Target Audience

This activity has been designed to meet the educational needs of pulmonologists and other clinicians involved in idiopathic pulmonary fibrosis.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: June 26, 2017 - June 25, 2018
Time to Complete: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, the University of Cincinnati has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director
Paul W. Noble, MD
Professor and Chair, Department of Medicine
Director, Women’s Guild Lung Institute
Vera and Paul Guerin Family Distinguished Chair in Pulmonary Medicine
Cedars-Sinai Medical Center
Los Angeles, California

Paul W. Noble, MD, has a financial interest/relationship or affiliation in the form of:
Speakers Bureau participant with Boehringer Ingelheim GmbH and Genentech, Inc.

CME Accreditation
Deborah Cole, BS
Program Coordinator, Continuing Medical Education
University of Cincinnati
Cincinnati, Ohio

Deborah Cole, BS, has no financial interests/relationships or affiliations in relation to this activity.

Susan P. Tyler, MEd, CMP, CHCP
Director, Continuing Medical Education
University of Cincinnati
Cincinnati, OH

Susan P. Tyler, MEd, CMP, CHCP, has nothing to disclose.

CME Reviewer
Rick E. Ricer, MD
Professor Emeritus
University of Cincinnati
Cincinnati, OH

Rick E. Ricer, MD, has nothing to disclose.

Medical Director
Chris Washburn, PhD
PVI, PeerView Institute for Medical Education

Chris Washburn, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and PVI, PeerView Institute for Medical Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This CME activity is jointly provided by the University of Cincinnati and PVI, PeerView Institute for Medical Education.


This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.

Copyright © 2000-2017, PeerView Press

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.